UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003

Sellar, RS; Rowntree, C; Vora, AJ; Furness, CL; Goulden, N; Mitchell, C; Moorman, AV; (2018) Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003. British Journal of Haematology , 181 (4) pp. 515-522. 10.1111/bjh.15208. Green open access

[thumbnail of Sellar_BSH final 24.pdf]
Preview
Text
Sellar_BSH final 24.pdf - Accepted Version

Download (986kB) | Preview

Abstract

Outcomes for teenage and young adult (TYA) patients with acute lymphoblastic leukaemia (ALL) who relapse on contemporary risk‐adapted paediatric protocols are largely unknown and there is no consensus on optimal salvage strategies. We assessed the treatment and outcome of TYA patients (aged 16–24 years) recruited to the UKALL2003 trial, who relapsed following attainment of complete morphological remission. Forty‐two of 223 patients (18·8%) relapsed, the majority (n = 26, 62%) on treatment. Thirty‐eight (90%) patients received salvage treatment, with 22 (58%) achieving second remission (CR2) and 21 patients receiving an allogeneic haematopoietic cell transplant (alloHSCT). Post‐relapse outcomes were poor with a 5‐year overall survival (OS) of 23% (95% confidence interval; 11–37%). Outcomes for patients relapsing on active treatment were inferior to those relapsing after completing treatment (5‐year OS 9% vs. 52%, log‐rank P = 0·001). No patient with B cell ALL relapsing on treatment was alive at the end of the study period. TYA patients with ALL who relapse on the UK paediatric protocol, UKALL2003, are largely unsalvageable with conventional approaches aimed at achieving CR2 followed by alloHSCT. Future efforts should be aimed at identifying those patients who are destined to relapse and exploring novel treatment approaches for this high‐risk group and for those who do relapse.

Type: Article
Title: Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003
Event: 57th Annual Meeting of the American Society of Hematology
Open access status: An open access version is available from UCL Discovery
DOI: 10.1111/bjh.15208
Publisher version: https://doi.org/10.1111/bjh.15208
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: https://discovery.ucl.ac.uk/id/eprint/10112323
Downloads since deposit
127Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item